ISMPP Highlights
GPP 2022 Published in Annals of Internal Medicine
The GPP4 Steering Committee (SC) and ISMPP are excited to announce the publication of the updated Good Publication Practice guidelines (GPP 2022) for company-sponsored research in Annals of Internal Medicine. Access GPP 2022 in the August 30, 2022 issue of Annals…
“In The Know” – Key Updates in Medical Communications
This article shares information about: newly updated ICMJE recommendations; publications by ISMPP members covering parallel publication, plain language summaries, and a value-based metric framework; abstracts accepted for presentation at the 18th Annual Meeting; and posters presented at the 2022 European Meeting…
ISMPP Authorship Algorithm Tool – Ready to Use!
It’s Here! ISMPP is thrilled to announce the release of its Authorship Algorithm Tool, a web-based tool designed to help you better determine contributions to criterion 1 for authorship based on the ICMJE Recommendations. The Tool is available FREE to COMPANIES, with an ISMPP member serving as the Company Admin…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Top Tips for Getting Your Economic Evaluations Published: CHEERS to That!
The transparent reporting of economic evaluations is growing in importance, now that an increasing number of healthcare payers require health sciences companies to demonstrate that their products are not only clinically effective, but also cost-effective…
Real-world Strategies for Success with Simultaneous Publication of Industry-Sponsored Research
While the demand grows to publish and present industry-sponsored research in parallel, the need for collaboration among authors, journals/publishers, and congresses has evolved. This infographic article highlights approaches to optimize management of the overall development timeline…
Tactical Delivery of Medical Publications: A Visual Journey
Are you interested in guidance on the processes behind drafting and developing medical publications? View a stepwise visual guide on tactical delivery of medical publications that considers the roles and responsibilities of key stakeholders, best practices and how to adhere to industry standards, roles of pharma publication and agency teams, and more…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
To Use AI or To Not Use AI… for Manuscript Development? [redo]
You are a researcher working on a groundbreaking clinical study that could potentially lead to a significant advancement in the treatment of a complex disease. Some members of the research team want to use artificial intelligence (AI) to develop the first draft of the manuscript. Other team members are concerned about accuracy, interpretation, and potential bias in the content. What Would You Do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals